Previous reports show that significantly increased BMI1 expression in CD34+ cells in the peripheral blood and bone marrow of AML patients compared to normal cells is associated with worse prognosis [39, 48, 49]. This evidence concerns the gene BMI1 and acute myeloid leukemia.